Match!
Journal of Clinical Lipidology
IF
3.58
Papers
2171
Papers 2287
1 page of 229 pages (2,287 results)
Newest
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
Patrick M. Moriarty26
Estimated H-index: 26
(KU: University of Kansas),
Jessica V. Gray (KU: University of Kansas), Lauryn K. Gorby (KU: University of Kansas)
Abstract Background Elevated lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease (CVD). In the United States (US), lipoprotein apheresis (LA) therapy is approved for patients with familial hypercholesterolemia. Germany utilizes LA therapy for patients with an Lp(a) > 60 mg/dL, normal LDL-C levels, and CVD. LA therapy in this population demonstrated a > 70% reduction in CVD events. In the US, LA is only approved for patients with elevated LDL-C levels, regardless of Lp...
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
James M. Backes12
Estimated H-index: 12
(KU: University of Kansas),
Thomas D. Dayspring6
Estimated H-index: 6
,
Patrick M. Moriarty26
Estimated H-index: 26
(KU: University of Kansas)
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
Claudio Rabacchi9
Estimated H-index: 9
(University of Modena and Reggio Emilia),
Maria Luisa Simone8
Estimated H-index: 8
(University of Modena and Reggio Emilia)
+ 7 AuthorsPatrizia Tarugi27
Estimated H-index: 27
(University of Modena and Reggio Emilia)
Abstract Background Familial hypobetalipoproteinemia type 1 (FHBL-1) is a codominant disorder characterized by greatly reduced plasma levels of total cholesterol, low-density lipoprotein cholesterol and apolipoprotein B. Rare exonic pathogenic variants of APOB gene (nonsense variants, minute deletions/insertions and nonsynonymous variants) have been frequently reported in subjects with FHBL-1. Also rare intronic variants of APOB located at intron/exon junctions and assumed to affect splicing hav...
Published on 2019in Journal of Clinical Lipidology3.58
Ivana Semova4
Estimated H-index: 4
(Boston Children's Hospital),
Amy E. Levenson4
Estimated H-index: 4
(Boston Children's Hospital)
+ 7 AuthorsElaine M. Urbina41
Estimated H-index: 41
(Cincinnati Children's Hospital Medical Center)
Abstract Background To optimize treatment and prevent cardiovascular disease in subjects with type 1 diabetes, it is important to determine how cholesterol metabolism changes with type 1 diabetes. Objective To compare plasma levels of campesterol and β-sitosterol, markers of cholesterol absorption, as well as lathosterol, a marker of cholesterol synthesis, in youth with and without type 1 diabetes. Methods Serum samples were obtained from adolescent subjects with type 1 diabetes [n= 175, mean ag...
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
P.P. Toth (JHUSOM: Johns Hopkins University School of Medicine), Harold E. Bays54
Estimated H-index: 54
+ 7 AuthorsAndrew M. Tershakovec23
Estimated H-index: 23
(MSD: Merck & Co.)
Abstract Background —Elevated remnant-lipoprotein cholesterol (RLP-C) levels increase cardiovascular disease risk. However, RLP-C measurement methods are not standardized, leading to variations across studies. Objective —To evaluate the effect of ezetimibe (Eze)+statins vs statin monotherapy on RLP-C using immunoseparation (IM), vertical auto profile (VAP) ultracentrifugation, and calculated RLP-C measurement methods. Methods —This post-hoc analysis evaluated data pooled from 3 first-line (all-s...
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
Meng Jin2
Estimated H-index: 2
(Peking Union Medical College Hospital),
Xiaoyin Bai (Peking Union Medical College Hospital)+ 6 AuthorsHong Yang2
Estimated H-index: 2
(Peking Union Medical College Hospital)
Abstract Background Acute pancreatitis (AP) is an acute inflammation of the pancreas which caused increasing global health and economic burden. Longitudinal trends of disease etiology and its influence on prognosis remains unclear. Objective The aim of this study was to analyze the trend of etiology in moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP) and to evaluate the influence of the changing pattern of etiology. Methods A 16-year cohort study was undertaken in ...
Published on 2019in Journal of Clinical Lipidology3.58
Z. Petrulioniene6
Estimated H-index: 6
(Vilnius University),
U. Gargalskaite1
Estimated H-index: 1
(Vilnius University)
+ 3 AuthorsAlgirdas Utkus9
Estimated H-index: 9
Published on 2019in Journal of Clinical Lipidology3.58
Constance Cephus5
Estimated H-index: 5
(BCM: Baylor College of Medicine),
Athar M. Qureshi12
Estimated H-index: 12
(BCM: Baylor College of Medicine)
+ 1 AuthorsDouglas Moodie32
Estimated H-index: 32
(BCM: Baylor College of Medicine)
Abstract Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprotein cholesterol and thereby reduce risk of cardiovascular events. Angiographic evidence of regression of coronary artery disease is presented.
Published on Sep 1, 2019in Journal of Clinical Lipidology3.58
Carol Kirkpatrick2
Estimated H-index: 2
(ISU: Idaho State University),
J.P. Bolick (Intermountain Healthcare)+ 5 AuthorsKevin C. Maki43
Estimated H-index: 43
Abstract Historically, low-carbohydrate (CHO) and very-low-CHO diets have been used for weight loss. Recently, these diets have been promoted for type II diabetes management. This scientific statement provides a comprehensive review of the current evidence base available from recent systematic reviews and meta-analyses on the effects of low-CHO and very-low-CHO diets on body weight, lipoprotein lipids, glycemic control, and other cardiometabolic risk factors. In addition, evidence on emerging ri...
12345678910